Publications

Cases M, Ritter N, Rincon-Arevalo H, Kroh S, Adam A, Kirchner M, Moradian H, Gossen M, Dzamukova M, Manukyan A, Landthaler M, Kressler C, Hauser AE, Depledge DP, Polansky JK, Chang HD.
Novel non-coding FOXP3 transcript isoform associated to potential transcriptional interference in human regulatory T cells.
RNA Biol. 2025 Dec;22(1):1-20. doi: 10.1080/15476286.2025.2502719. Epub 2025 Jul 2. PMID: 40605177; PMCID: PMC12233831.

Mooser C, Ronchi F, Limenitakis JP, Kalbermatter C, Christensen S, de Agüero MG, Fuhrer T, Sauer U, Macpherson AJ, Ganal-Vonarburg SC.
Diet-derived LPS determines intestinal IgA induction and repertoire characteristics independently of the microbiota.
Immunity. 2025 Jul 8;58(7):1778-1793.e7. doi: 10.1016/j.immuni.2025.05.024. Epub 2025 Jun 26. PMID: 40578363.

Passen CV, Krug J, Weiß L, Abdou MM, Tripal P, Schmid B, Krüger R, Lyu Y, Zohud BA, Petter K, Geppert C, Merkel S, Bärthlein B, Busenhart P, Scharl M, Naschberger E, Stürzl M.
Integrin β6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin.
Int J Cancer. 2025 Oct 1;157(7):1481-1495. doi: 10.1002/ijc.35504. Epub 2025 Jun 9. PMID: 40488391; PMCID: PMC12334909.

Krug SM, Lee IM, Knobe L, Hartmannsberger B, Atalla MS, Rittner HL, Fromm M.
Characterising epi-perineurial barrier function by microscale techniques including a miniaturised Ussing chamber.
Acta Biomater. 2025 Jun 1;199:290-300. doi: 10.1016/j.actbio.2025.04.043. Epub 2025 Apr 22. PMID: 40274060.

Trajanoski Z, Plattner C, Sturm G, Kühl A, Atreya R, Carollo S, Gronauer R, Rieder D, Günther M, Ormanns S, Manzl C, Wirtz S, Meneghetti A, Hegazy A, Patankar J, Carrero Z, Neurath M, Kather J, Becker C, Siegmund B.
IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases.
Res Sq [Preprint]. 2025 May 6:rs.3.rs-6443303. doi: 10.21203/rs.3.rs-6443303/v1. PMID: 40386420; PMCID: PMC12083645.

Yong Y, Demmler R, Zohud BA, Fang Q, Zhang T, Zhou Y, Petter K, Flierl C, Gass T, Geppert CI, Merkel S, Schellerer VS, Naschberger E, Stürzl M.
AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes.
J Pathol. 2025 Jan;265(1):14-25. doi: 10.1002/path.6363. Epub 2024 Nov 11. PMID: 39523830; PMCID: PMC11638658.

Budzinski L, Kang GU, Riedel R, Sempert T, Lietz L, Maier R, Büttner J, Bochow B, Tordai MT, Shah A, Abbas A, Momtaz T, Krause JL, Kempkens R, Lehman K, Heinz GA, Benken AE, Bartsch S, Necke K, Hoffmann U, Mashreghi MF, Biesen R, Kallinich T, Alexander T, Jessen B, Weidinger C, Siegmund B, Radbruch A, Schirbel A, Moser B, Chang HD.
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease.
Gut Microbes. 2025 Dec;17(1):2452250. doi: 10.1080/19490976.2025.2452250. Epub 2025 Jan 15. PMID: 39815413; PMCID: PMC11740678.

Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath MF, Dörje F, Atreya R.
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
Inflamm Bowel Dis. 2025 Jan 6;31(1):77-86. doi: 10.1093/ibd/izae040.

Stallmach A, Stallhofer J, Schmidt C, Atreya R, Grunert PC.
Therapie des schweren Schubs bei Morbus Crohn und Colitis ulcerosa [Treatment of severe flares in Crohn’s disease and ulcerative colitis].
Inn Med (Heidelb). 2025 Jan;66(1):22-30. German. doi: 10.1007/s00108-024-01825-w.

Atreya R, Rath T, Neurath MF.
Molecular Imaging: The New Frontier for Endoscopic Diagnosis and Personalization in Inflammatory Bowel Disease.
Gastrointest Endosc Clin N Am. 2025 Jan;35(1):255-263. doi: 10.1016/j.giec.2024.09.002.

Bao LL, Yu YQ, González-Acera M, Patankar JV, Giessl A, Sturm G, Kühl AA, Atreya R, Erkert L, Gámez-Belmonte R, Krug SM, Schmid B, Tripal P, Chiriac MT, Hildner K, Siegmund B, Wirtz S, Stürzl M, Mohamed Abdou M, Trajanoski Z; TRR241 IBDome Consortium; Neurath MF, Zorzano A, Becker C.
Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease.
Sci Transl Med. 2025 Jan 15;17(781):eadn8699. doi: 10.1126/scitranslmed.adn8699.

Müller TM, Liu LJ, Wiesinger M; TRR241 IBDome Consortium; Neurath MF, Voskens CJ, Zundler S.
Engineering Therapeutic Regulatory T Cells to Overexpress G Protein-Coupled Receptor 15 Improves Functional Fitness for In Vivo Gut Homing.
Gastroenterology. 2025 Feb;168(2):389-392.e4. doi: 10.1053/j.gastro.2024.10.003.

Roth D, Düll MM, Horst LJ, Lindemann A, Malzer X, Koop K, Zundler S, Vetter M, Jefremow A, Atreya R, Geppert C, Weidemann S, Waldner MJ, Dietrich P, Günther C, Munoz LE, Herrmann M, Scheffold A, Neurath MF, Siebler J, Schramm C, Kremer AE, Leppkes M.
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
J Crohns Colitis. 2025 Feb 4;19(2):jjae131. doi: 10.1093/ecco-jcc/jjae131.

Horn V, Cancino CA, Steinheuer LM, Obermayer B, Fritz K, Nguyen AL, Juhran KS, Plattner C, Bösel D, Oldenburg L, Burns M, Schulz AR, Saliutina M, Mantzivi E, Lissner D, Conrad T, Mashreghi MF, Zundler S, Sonnenberg E, Schumann M, Haag LM, Beule D, Flatz L; TRR241 IBDome Consortium; Trajanoski Z, D’Haens G, Weidinger C, Mei HE, Siegmund B, Thurley K, Hegazy AN.
Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7-Blocking Therapy in Inflammatory Bowel Disease.
Gastroenterology. 2025 Feb;168(2):327-343. doi: 10.1053/j.gastro.2024.09.021.

Beck M, Kuwert T, Atzinger A, Gerner M, Hartmann A, Saake M, Uder M, Neurath MF, Atreya R.
Discrimination between Inflammatory and Fibrotic Activity in Crohn’s Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging.
Visc Med. 2025 Feb;41(1):1-13. doi: 10.1159/000542160.

Atreya R, Neurath MF.
No easy way out: blocking lymphocyte egress by the S1P1 receptor 1 modulator tamuzimod in ulcerative colitis.
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):185-187. doi: 10.1016/S2468-1253(24)00397-2.

Feng X, Andersson T, Flüchter P, Gschwend J, Berest I, Muff JL, Lechner A, Gondrand A, Westermann P, Brander N, Carchidi D, De Tenorio JC, Pan T, Boehm U, Klose CSN, Artis D, Messner CB, Leinders-Zufall T, Zufall F, Schneider C.
Tuft cell IL-17RB restrains IL-25 bioavailability and reveals context-dependent ILC2 hypoproliferation.
Nat Immunol. 2025 Apr;26(4):567-581. doi: 10.1038/s41590-025-02104-y.

Gonzalez-Acera M, Patankar JV, Erkert L, Cineus R, Gamez-Belmonte R, Leupold T, Bubeck M, Bao LL, Dinkel M, Wang R, Schickedanz L, Limberger H, Stolzer I, Gerlach K, Diemand L, Mascia F, Gupta P, Naschberger E, Koop K, Plattner C, Sturm G, Weigmann B, Günther C, Wirtz S, Stürzl M, Hildner K, Kühl AA, Siegmund B, Gießl A, Atreya R; TRR241 IBDome Consortium; Hegazy AN, Trajanoski Z, Neurath MF, Becker C.
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD.
Gut. 2025 Apr 29:gutjnl-2024-333729. doi: 10.1136/gutjnl-2024-333729.

Plattner C, Sturm G, Kühl AA, Atreya R, Carollo S, Gronauer R, Rieder D, Günther M, Ormanns S, Manzl C, Wirtz S, Meneghetti AR, Hegazy AN, Patankar JV, Carrero ZI; TRR241 IBDome Consortium; Neurath MF, Kather JN, Becker C, Siegmund B, Trajanoski Z.
IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseases.
bioRxiv [Preprint]. 2025 Apr 10:2025.03.26.645544. doi: 10.1101/2025.03.26.645544.

Erkert L, Ruder B, Kabisch M, Gamez Belmonte R, Patankar JV, Gonzalez Acera M, Schödel L, Chiriac MT, Cineus R, Gnafakis S, Leupold T, Thoma OM, Stolzer I, Taut A, Thonn V, Zundler S, Günther C, Diefenbach A, Kühl AA, Hegazy AN, Waldner M, Basic M, Bleich A, Neurath MF, Wirtz S, Becker C; TRR241 IBDome Consortium.
TIFA renders intestinal epithelial cells responsive to microbial ADP-heptose and drives colonic inflammation in mice.
Mucosal Immunol. 2025 Apr;18(2):453-466. doi: 10.1016/j.mucimm.2025.01.003.

Hecker J, Plattner C, Cancino CA, Löscher BS, Saurenbach J, Letizia M, Rieder D; TRR241 IBDome Consortium; Freise I, Koop K, Neufert C, Kunkel D, Al Khatim Z, Schaafs LA, Schütz A, Becker C, Atreya R, Trajanoski Z, Franke A, Sonnenberg E, Hegazy AN, Siegmund B, Weidinger C.
IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations.
EMBO Mol Med. 2025 May 30. doi: 10.1038/s44321-025-00245-z.

Avery EG, Haag LM, McParland V, Kedziora SM, Zigra GJ, Valdes DS, Kirchner M, Popp O, Geisberger S, Nonn O, Karlsen TV, N’Diaye G, Yarritu A, Bartolomaeus H, Bartolomaeus TUP, Tagiyeva NA, Wimmer MI, Haase N, Zhang YD, Wilhelm A, Grütz G, Tenstad O, Wilck N, Forslund SK, Klopfleisch R, Kühl AA, Atreya R, Kempa S, Mertins P, Siegmund B, Wiig H, Müller DN.
Intestinal interstitial fluid isolation provides novel insight into the human host-microbiome interface.
Cardiovasc Res. 2025 May 23;121(5):803-816. doi: 10.1093/cvr/cvae267.

Forster PM, Jakob MO, Yusuf D, Bubeck M, Limberger H, Luo Y, Thieme P, Polici A, Sterczyk N, Boulekou S, Bartel L, Cosovanu C, Witkowski M, González-Acera M, Kühl AA, Weidinger C; TRR241 IBDome Consortium; Backofen R, Hegazy AN, Patankar JV, Klose CSN.
A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation.
Neuron. 2025 May 7;113(9):1333-1351.e7. doi: 10.1016/j.neuron.2025.02.018.

Lehmann M, Paclik D, Huck A, Arnold A, Kurth-Stavenhagen C, Vieth M, Treese C, Kühl AA, Siegmund B.
Spatial immune profiling of Crohn’s disease fistula carcinomas-defining a distinct cancer subtype.
J Crohns Colitis. 2025 Jun 4;19(6):jjaf086. doi: 10.1093/ecco-jcc/jjaf086.

Cineus R, Luo Y, Saliutina M, Manna S, Cancino CA, Velasco Blázquez L, Wang L, Bösel D, Abdelrahman A, Klementowicz JE, Scherl A, Hainbuch S, Bréart B, Kwon G, Konopka A, Guerra GM, von Coburg E, Gerbeth L, Roels J, Heinrich F, Müller N, Durek P, Deigendesch N, Ziai J, Hung J, Conrad T; TRR241 IBDome Consortium; Kühl AA, Wirtz S, Löhning M, Keir M, Diefenbach A, Mashreghi MF, Siegmund B, Schumann M, Romagnani C, West NR, Hegazy AN.
The IL-22-oncostatin M axis promotes intestinal inflammation and tumorigenesis.
Nat Immunol. 2025 Jun;26(6):837-853. doi: 10.1038/s41590-025-02149-z.

Neurath MF, Artis D, Becker C.
The intestinal barrier: a pivotal role in health, inflammation, and cancer.
Lancet Gastroenterol Hepatol. 2025 Jun;10(6):573-592. doi: 10.1016/S2468-1253(24)00390-X.

Atreya R, Neurath MF.
MRI Volumetric Changes in Perianal Fistulizing Crohn’s Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response.
United European Gastroenterol J. 2025 Jun;13(5):667-668. doi: 10.1002/ueg2.12765.

Liu LJ, Müller TM, Dedden M, Schramm S, Leppkes M, Atreya R, Atreya I; TRR241 IBDome consortium; Neurath MF, Zundler S.
ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanism.
J Crohns Colitis. 2025 Jun 10:jjaf097. doi: 10.1093/ecco-jcc/jjaf097.

Erkert L, Kabisch M, Gamez-Belmonte R, Gonzalez-Acera M, Patankar JV, Schödel L, Hofmann K, Wagner Y, Plattner C, Spath EM, Distler U, Tenzer S; TRR241 IBDome Consortium; Neufert C, Neurath MF, Becker C.
Pharmacological inhibitors of the gamma-secretase enzyme complex disrupt epithelial cell function triggering colitis in mice.
J Crohns Colitis. 2025 Jun 12:jjaf096. doi: 10.1093/ecco-jcc/jjaf096.

Masanetz RK, Mundlos H, Stolzer I, Winkler J, Günther C, Süß P.
Absence of Microglial Activation and Maintained Hippocampal Neurogenesis in a Transgenic Mouse Model of Crohn’s Disease.
Cells. 2025 Jun 4;14(11):841. doi: 10.3390/cells14110841.

Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, Durek P, Tizian C, Sterczyk N, Helfrich S, Duerr CU, Voehringer D, Witkowski M, Artis D, Rollenske T, Kruglov AA, Mashreghi MF, Klose CSN.
Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.
Nat Commun. 2024 Dec 4;15(1):10566. doi: 10.1038/s41467-024-54780-3. PMID: 39632879; PMCID: PMC11618303.

Budzinski L, Sempert T, Lietz L, Maier R, Kang GU, von Stuckrad ASL, Goetzke CC, Roth M, Shah A, Abbas A, Lehman K, Necke K, Bartsch S, Hoffmann U, Mashreghi MF, Biesen R, Kallinich T, Chang HD.
Age-stratification reveals age-specific intestinal microbiota signatures in juvenile idiopathic arthritis.
Mol Cell Pediatr. 2024 Dec 10;11(1):12. doi: 10.1186/s40348-024-00186-6. PMID: 39653980; PMCID: PMC11628465.

Saggau C, Bacher P, Esser D, Rasa M, Meise S, Mohr N, Kohlstedt N, Hutloff A, Schacht SS, Dargvainiene J, Martini GR, Stürner KH, Schröder I, Markewitz R, Hartl J, Hastermann M, Duchow A, Schindler P, Becker M, Bautista C, Gottfreund J, Walter J, Polansky JK, Yang M, Naghavian R, Wendorff M, Schuster EM, Dahl A, Petzold A, Reinhardt S, Franke A, Wieczorek M, Henschel L, Berger D, Heine G, Holtsche M, Häußler V, Peters C, Schmidt E, Fillatreau S, Busch DH, Wandinger KP, Schober K, Martin R, Paul F, Leypoldt F, Scheffold A.
Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases.
Immunity. 2024 Oct 8;57(10):2416-2432.e8. doi: 10.1016/j.immuni.2024.08.005. Epub 2024 Sep 2. PMID: 39226901.

Biniaris-Georgallis SI, Aschman T, Stergioula K, Schreiber F, Jafari V, Taranko A, Karmalkar T, Kasapi A, Lenac Rovis T, Jelencic V, Bejarano DA, Fabry L, Papacharalampous M, Mattiola I, Molgora M, Hou J, Hublitz KW, Heinrich F, Guerra GM, Durek P, Patone G, Lindberg EL, Maatz H, Hölsken O, Krönke G, Mortha A, Voll RE, Clarke AJ, Hauser AE, Colonna M, Thurley K, Schlitzer A, Schneider C, Stamatiades EG, Mashreghi MF, Jonjic S, Hübner N, Diefenbach A, Kanda M, Triantafyllopoulou A.
Amplification of autoimmune organ damage by NKp46-activated ILC1s.
Nature. 2024 Oct;634(8035):952-960. doi: 10.1038/s41586-024-07907-x. Epub 2024 Aug 13. PMID: 39137897.

Krause JL, Engelmann B, Lallinger DJD, Rolle-Kampczyk U, von Bergen M, Chang HD.
Multi-Omics Analysis Unravels the Impact of Stool Sample Logistics on Metabolites and Microbial Composition.
Microorganisms. 2024 Sep 30;12(10):1998. doi: 10.3390/microorganisms12101998. PMID: 39458307; PMCID: PMC11509235.

Wagner K, Müller TM, Vitali F, Fischer S, Haberkamp S, Rouse-Merkel R, Atreya R, Neurath MF, Zundler S.
Treatment trajectories and outcomes in inflammatory bowel disease: a tertiary single-centre experience.
Therap Adv Gastroenterol. 2024 Sep 28;17:17562848241284051. doi: 10.1177/17562848241284051. PMID: 39381754; PMCID: PMC11459667.

Schramm S, Liu LJ, Saad M, Dietz L, Dedden M, Müller TM, Atreya I, Voskens CJ, Atreya R, Neurath MF, Zundler S.
Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in Vivo.
J Crohns Colitis. 2024 Aug 6;18(7):1162-1172. doi: 10.1093/ecco-jcc/jjae012. PMID: 38243565.

Topczewska PM, Savvopoulou A, Cosovanu C, Klose CSN.
Transcriptional profiling identifies IL-33-expressing intestinal stromal cells as a signaling hub poised to interact with enteric neurons.
Front Cell Dev Biol. 2024 Aug 1;12:1420313. doi: 10.3389/fcell.2024.1420313. PMID: 39149516; PMCID: PMC11325031.

Dorner H, Stolzer I, Mattner J, Kaminski S, Leistl S, Edrich LM, Schwendner R, Hobauer J, Sebald A, Leikam S, Gonzalez Acera M, Düll M, Lang R, Seidel G, Seitz T, Hellerbrand C, Fuhrmann G, Distler U, Tenzer S, Eichhorn P, Vieth M, Schramm C, Arnold P, Becker C, Weidinger C, Siegmund B, Atreya R, Leppkes M, Naschberger E, Sampaziotis F, Dietrich P, Rauh M, Wirtz S, Kremer AE, Neurath MF, Günther C.
Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
Gastroenterology. 2024 Nov;167(6):1183-1197.e16. doi: 10.1053/j.gastro.2024.06.032. Epub 2024 Jul 9. PMID: 38992449.

Atreya I, Neurath MF.
Linking IL-10 signaling with lipid metabolic programs in macrophages: dysregulated ceramide homeostasis drives colitis.
Signal Transduct Target Ther. 2024 Jun 8;9(1):156. doi: 10.1038/s41392-024-01864-7. PMID: 38851767; PMCID: PMC11162417.
Projekte: A07, C04

Hegazy AN, Peine C, Niesen D, Panse I, Vainshtein Y, Kommer C, Zhang Q, Brunner TM, Peine M, Fröhlich A, Ishaque N, Marek RM, Zhu J, Höfer T, Löhning M.
Plasticity and lineage commitment of individual TH1 cells are determined by stable T-bet expression quantities.
Sci Adv. 2024 Jun 7;10(23):eadk2693. doi: 10.1126/sciadv.adk2693. Epub 2024 Jun 5. PMID: 38838155; PMCID: PMC11152138.

Weber S, Sitte S, Voegele AL, Sologub L, Wilfer A, Rath T, Nägel A, Zundler S, Franchi L, Opipari AW, Sonnewald S, Reid S, Hartmann A, Eichhorn P, Handtrack C, Weber K, Grützmann R, Neufert C, Schellerer VS, Naschberger E, Ekici AB, Büttner C, Neurath MF, Atreya R.
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases.
J Crohns Colitis. 2024 Mar 1;18(3):446-461. doi: 10.1093/ecco-jcc/jjad164. PMID: 37748021.

Thoma OM, Naschberger E, Kubánková M, Larafa I, Kramer V, Menchicchi B, Merkel S, Britzen-Laurent N, Jefremow A, Grützmann R, Koop K, Neufert C, Atreya R, Guck J, Stürzl M, Neurath MF, Waldner MJ.
p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer.
Gastroenterology. 2024 Feb;166(2):284-297.e11. doi: 10.1053/j.gastro.2023.09.017. Epub 2023 Sep 19. PMID: 37734420.

Chiriac MT, Hracsko Z, Günther C, Gonzalez-Acera M, Atreya R, Stolzer I, Wittner L, Dressel A, Schickedanz L, Gamez-Belmonte R, Erkert L, Hundorfean G, Zundler S, Rath T, Vetrano S, Danese S, Sturm G, Trajanoski Z, Kühl AA, Siegmund B, Hartmann A, Wirtz S, Siebler J, Finotto S, Becker C, Neurath MF.
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.
Gut. 2024 Jan 5;73(2):282-297. doi: 10.1136/gutjnl-2023-329628. PMID: 37884352; PMCID: PMC10850655.

Fischer S, Donhauser M, Cohnen S, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, Rath T, Wilfer A, Sologub L, Krebs S, Dörje F, Nagore D, Meyer S, Neurath MF, Atreya R.
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
Therap Adv Gastroenterol. 2024 Nov 30;17:17562848241301887. doi: 10.1177/17562848241301887. PMID: 39619829; PMCID: PMC11608450.

Voges L, Weiß F, Branco AT, Fromm M, Krug SM.
Expression and Localization Profiles of Tight Junction Proteins in Immune Cells Depend on Their Activation Status.
Int J Mol Sci. 2024 Apr 29;25(9):4861. doi: 10.3390/ijms25094861. PMID: 38732086; PMCID: PMC11084252.

Wiese JJ, Manna S, Kühl AA, Fascì A, Elezkurtaj S, Sonnenberg E, Bubeck M, Atreya R, Becker C, Weixler B, Siegmund B, Patankar JV, Prüß MS, Schumann M.
Myenteric Plexus Immune Cell Infiltrations and Neurotransmitter Expression in Crohn’s Disease and Ulcerative Colitis.
J Crohns Colitis. 2024 Jan 27;18(1):121-133. doi: 10.1093/ecco-jcc/jjad122. PMID: 37565754; PMCID: PMC10821712.

Almalla A, Alzain N, Elomaa L, Richter F, Scholz J, Lindner M, Siegmund B, Weinhart M.
Hydrogel-Integrated Millifluidic Systems: Advancing the Fabrication of Mucus-Producing Human Intestinal Models.
Cells. 2024 Jun 21;13(13):1080. doi: 10.3390/cells13131080. PMID: 38994934; PMCID: PMC11240340.